Evaluation of growth hormone deficiency in women with unexplained infertility

Mehmet Serif Ortac,Aysa Hacioglu,Semih Zeki Uludag,Zuleyha Karaca,Kursad Unluhizarci,Fahrettin Kelestimur,Fatih Tanriverdi

DOI: https://doi.org/10.1016/j.ghir.2024.101571

IF: 2.125

2024-01-24

Growth Hormone & IGF Research

Abstract:Purpose Growth hormone (GH) has been recognized to play a regulatory role in female reproduction. It has been reported that infertile GH deficient patients regained fertility after GH replacement. The frequency of GH deficiency is not established in patients diagnosed with unexplained infertility. Here, we aim to present the prevalence of GH deficieny in this patient group. Methods We included patients diagnosed with unexplained infertility throughout 18 months. Insulin tolerance test (ITT) and glucagon stimulation tests (GST) were performed and insufficient response to both tests was required for the diagnosis of GH deficiency. Results Twenty-five patients were included in the study, the mean age was 27.4 ± 4.5 years and the median duration of infertility was 60 months (min:14, max:120). Two patients were GH deficient according to GST and 14 to ITT. Two patients (8%) showed lack of response on both tests and were diagnosed with GH deficiency. Conclusion The rate of GH deficiency among women with unexplained infertility was 8% in this preliminary study. There is need for further studies with larger patient groups to verify the results.

cell biology,endocrinology & metabolism